VIEWPOINT THERAPEUTICS
ViewPoint Therapeutics is a biotechnology company dedicated to the development of treatments for diseases of protein misfolding, including cataracts. The company's crystallin stabilizers include a small molecule that is active in preclinical models of age-related cataracts via a target-based screening and optimization effort, providing physicians with drugs to prevent or reverse protein misfolding, which is implicated in numerous common disorders of aging including cataracts, presbyopia, and neurodegenerative diseases.
VIEWPOINT THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2014-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.viewpointtherapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
39 M USD
Technology used in webpage:
SPF Invalid Certificate Dates Hawk Host Hawkhost DNS
Similar Organizations
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Novo Ventures
Novo Ventures investment in Series B - ViewPoint Therapeutics
Lagunita BioSciences
Lagunita BioSciences investment in Series B - ViewPoint Therapeutics
The Rise Fund
The Rise Fund investment in Series B - ViewPoint Therapeutics
Mission BioCapital
Mission BioCapital investment in Series B - ViewPoint Therapeutics
Biotechnology Value Fund
Biotechnology Value Fund investment in Series B - ViewPoint Therapeutics
Mission Bay Capital
Mission Bay Capital investment in Series B - ViewPoint Therapeutics
Mission Bay Capital
Mission Bay Capital investment in Series A - ViewPoint Therapeutics
Lagunita BioSciences
Lagunita BioSciences investment in Series A - ViewPoint Therapeutics
Asset Management Ventures (AMV)
Asset Management Ventures (AMV) investment in Series A - ViewPoint Therapeutics
Official Site Inspections
http://www.viewpointtherapeutics.com
- Host name: 104.21.2.104
- IP address: 104.21.2.104
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "ViewPoint Therapeutics"
ViewPoint Therapeutics - Crunchbase Company Profile โฆ
Contact Email [email protected] ViewPoint Therapeutics is a biotechnology company dedicated to the development of treatments for โฆSee details»
ViewPoint Therapeutics - PitchBook
ViewPoint Therapeutics General Information Description. Developer of crystallin stabilizers designed to prevent and treat cataracts and presbyopia. The โฆSee details»
ViewPoint Therapeutics - Company Profile - Tracxn
Feb 28, 2025 Email ID: *****@viewpointtherapeutics.com; Key Metrics. Total Funding. $39M in 2 rounds. Latest Funding Round. Series B, Mar 05, 2018, $35M. Investors. Mission Bay Capital โฆSee details»
ViewPoint Therapeutics Inc - Company Profile and News
Company profile page for ViewPoint Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
viewpointtherapeutics.com
Viewpointtherapeutics.comSee details»
ViewPoint Therapeutics - Products, Competitors, Financials, โฆ
Headquarters Location. 953 Indiana Street . San Francisco, California, 94107, United States. 734-205-8246See details»
ViewPoint Therapeutics - VentureRadar
Website: http://www.viewpointtherapeutics.com/ Develops treatments for protein misfolding diseases, including cataracts, aiming to revitalize vision loss treatment ...See details»
ViewPoint Therapeutics - Craft
ViewPoint Therapeutics is a biotechnology company which develops treatments for diseases of protein misfolding, including cataracts. To address the need for new methods to treat cataracts โฆSee details»
ViewPoint Therapeutics Overview | SignalHire Company Profile
ViewPoint Therapeutics is a private company that has been in the industry for 8 years. The company currently specializes in the Research, Pharmaceuticals areas. The position of the โฆSee details»
Viewpoint Therapeutics, Inc. (Viewpoint Therapeutics, Inc.) - ่ฏ็ฉ โฆ
Company will begin trading on Nasdaq under trading symbol "SYRE" effective November 28, 2023 Biotechnology leader Cameron Turtle, DPhil, appointed as Chief Executive Officer and โฆSee details»
ViewPoint Therapeutics Raises $4 Million in Series A
May 5, 2016 Contact Data Investor and Media Contact: Denise Powell 510.703.9491 [email protected]See details»
ViewPoint Therapeutics | Insights
Mar 6, 2018 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
ViewPoint Therapeutics_ๅป็้กน็ฎ_ๅจ่็ฝๆฐๆฎ
ๅจ่็ฝๆฐๆฎๅบ๏ผViewPoint Therapeuticsๆฏไธๅฎถ็็ฉๆๆฏๅ ฌๅธ๏ผ่ดๅไบๅผๅ่็ฝ่ดจ้่ฏฏๆๅ ็พ็ ็ๆฒป็ๆนๆณ๏ผๅ ๆฌ็ฝๅ ้ใ่ฏฅๅ ฌๅธ็ๆถไฝ่็ฝ็จณๅฎๅๅ ๆฌไธ็งๅฐๅๅญ๏ผ้่ฟๅบไบ็ฎๆ ็็ญ้ๅไผ โฆSee details»
ViewPoint Therapeutics Raises $35 Million in Series B Financing
Mar 5, 2018 Proceeds will advance lead product candidate through clinical proof-of-concept studies in cataracts and presbyopia Series B led by The Rise Fund, a global impact fund SAN โฆSee details»
Viewpoint therapeutics Reviews | Read Client Reviews of Viewpoint ...
Read reviews of Viewpoint therapeutics. Write and share your personal story. Your experience will help others make the right buying decision.See details»
ViewPoint Therapeutics - VentureRadar
Open PageRank: 3,180,935 | viewpointtherapeutics.com. VentureRadar Popularity. Medium. VentureRadar Popularity: Medium. The popularity score combines profile views, clicks and the โฆSee details»
What is ViewPoint Therapeutics? Company Culture, Mission, Values
Glassdoor gives you an inside look at what it's like to work at ViewPoint Therapeutics, including salaries, reviews, office photos and more. This is the ViewPoint Therapeutics company profile.See details»
ViewPoint Therapeutics Raises $35 Million in Series B
Mar 5, 2018 For more information, please visit www.viewpointtherapeutics.com. About The Rise Fund The Rise Fund is a global fund committed to achieving measurable, positive social and โฆSee details»
NIH-funded research team engineers new drug targeting pain โฆ
Mar 5, 2025 Study of CB1 receptor has implications for chronic pain treatment. WHAT: A research team funded by the National Institutes of Health has developed a medication that โฆSee details»
Home - Tenpoint Therapeutics
Our team is focused on developing groundbreaking treatments for rejuvenating sight in the aging eye. We are developing paradigm-shifting treatments for the largest ophthalmic indications โฆSee details»